cabaten/getne-t1914: cabozantinib plus atezolizumab in adrenocortical carcinoma
Published 6 months ago • 64 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
2:34
cabozantinib demonstrates disease control in advanced adrenocortical carcinoma
-
5:05
cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
-
3:54
papmet2: cabozantinib with or without atezolizumab in prcc
-
4:15
contact-303: primary pfs analysis of atezolizumab and cabozantinib in ccrcc
-
2:22
cosmic-021: cabozantinib atezolizumab gives clinical activity in inoperable metastatic uc
-
12:41
cabozantinib in combination with atezolizumab in patients with mcrpc
-
2:27
hnrnpab:a key molecule in early metastasis of pancreatic ductal adenocarcinomas
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
3:51
achieving a higher pcr rate with nab-paclitaxel in breast cancer
-
1:13
dr. agarwal on data with cabozantinib/atezolizumab in mcrpc
-
3:56
phase ii trial of pembrolizumab & cabozantinib in patients with recurrent metastatic hnscc
-
1:38
calgb 49907 trial: standard chemotherapy versus capecitabine for older women with breast cancer
-
7:08
final analysis of the atlantis cabozantinib comparison
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
1:53
contact-2: cabozantinib and atezolizumab in mcrpc
-
0:51
dr. pal on the rationale for adding cabozantinib to atezolizumab in prostate cancer
-
0:55
dr. chan on trial of cabozantinib in neuroendocrine tumors
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma